Authors: Mike Clements, Cristina Altrocchi, Devon Guerrelli, Adam P. Hill, Nikki Posnack, Chris Strock, and Takashi Yoshinaga
Axion BioSystems, GA, USA; Johnson & Johnson, Belgium; Children’s National Hospital, DC, USA; Victor Chang Cardiac Research Institute, Australia; Cyprotex, MA, USA; Eisai Co., Ltd, Japan
Presented at ISSCR 2025 on June 11th, 2025 by Mike Clements, PhD
Axion iPSC Model Standards (AIMS)
AIMS seeks to leverage the expertise of key opinion leaders in the field and set minimum acceptance criteria for stem-derived model activity when used in Maestro MEA assays.
